TABLE 2.

Telavancin MIC distribution for 5,000 MRSA isolates collected in four geographic regions in 2007 and 2008

Region (no. of isolates tested)	% Occurrence at telavancin MIC (μg/ml) of:
	≤0.015	0.03	0.06	0.12	0.25	0.5
North America (2,500)	0.1	0.1	3.8	62.8a	31.4	1.8
Europe (1,000)		0.1	8.1	61.7	29.4	0.7
APAC (1,000)			2.3	39.6	50.7	7.4
Latin America (500)		0.2	1.0	37.8	55.4	5.6
All (5,000)	<0.1	<0.1	4.1	55.5	37.2	3.1

^aModal MICs are in bold.